EUVIMEDEUVIMED entdecken
Vergleichsstudie

Clinical outcomes in oocyte donation cycles: GnRH-antagonists versus progesterone-primed ovarian stimulation with micronized progesterone

Maria Martinez-Moya, Jaime Guerrero, Jose Antonio Ortiz, Jorge Ten, Belen Lledo, Andrea Bernabeu, Rafael Bernabeu, Juan C Castillo

Reproductive BioMedicine Online · 2025-07 · 51 (1) · 104864

DOI: 10.1016/j.rbmo.2025.104864 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Reproductive BioMedicine Online, 2025-07. Verfasst von Maria Martinez-Moya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departament of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain. Hauptthemen laut MEDLINE: Ovulation Induction, Oocyte Donation, Gonadotropin-Releasing Hormone, Progesterone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: In oocyte donation cycles, does the use of oral natural micronized progesterone (NMP) result in comparable clinical outcomes, compared with gonadotrophin releasing hormone (GnRH) antagonist treatment? DESIGN: Retrospective analysis of 1368 oocyte donation cycles (January 2018 to December 2022), and laboratory (n = 793) and clinical outcomes (n = 645) in matched recipients. Donors initiated ovarian stimulation in early follicular phase. To prevent a premature LH peak, the study group received natural micronized progesterone orally concurrently with FSH administration, whereas the control group began GnRH antagonist treatment in a flexible protocol. Live birth rate was the primary outcome. RESULTS: Duration of stimulation and total gonadotrophins dose were comparable between groups. The NMP group yielded significantly higher retrieved oocytes (15.9 ± 8.5 versus 13.1 ± 7.9; P < 0.001) and mature oocytes (12.8 ± 7.3 versus 11.7 ± 7.3; P = 0.003), and a lower maturation rate (80.89 ± 16.78% versus 89.49 ± 14.48%; P < 0.001). These donors had higher fertilization rates (81.3% versus 74.3%; P < 0.001) and number of usable embryos (4.6 ± 2.0 versus 4.1 ± 2.0; P < 0.001) compared with those treated with a GnRH antagonist. In matched recipients undergoing fresh embryo transfer, reproductive outcomes, including live birth rates, were similar in the GnRH antagonist and NMP groups (47.2% and 44.6%). CONCLUSIONS: Comparable live birth rates were found in fresh embryo transfers for recipients across both groups. The NMP protocol was associated with a higher number of mature oocytes but lower oocyte maturation rate, higher fertilization rates and number of usable blastocysts. Progesterone priming may positively influence oocyte donation cycles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionOocyte DonationGonadotropin-Releasing HormoneProgesteroneHormone AntagonistsHumansFemaleAdultRetrospective StudiesPregnancyPregnancy RateBirth RateFertilization in Vitro

Stichwörter der Autor:innen

GnRH-antagonistLive birth rateMII oocytesNatural micronized progesteroneOocyte donationProgesterone-primed ovarian stimulation

Substanzen

Gonadotropin-Releasing HormoneProgesteroneHormone Antagonists

Autor:innen und Institutionen

  • Departament of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain.
  • IBBIOTECH. Alicante, Spain; Biostatistics Department, Instituto Bernabeu, Alicante, Spain.
  • IBBIOTECH. Alicante, Spain.
  • Departament of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain; Cátedra de Medicina Comunitaria y Salud Reproductiva, Miguel Hernández University, Alicante, Spain.
  • Departament of Reproductive Medicine, Instituto Bernabeu, Alicante, Spain; Cátedra de Medicina Comunitaria y Salud Reproductiva, Miguel Hernández University, Alicante, Spain. Electronic address: jcastillo@institutoberna…

Zitieren

APA

Martinez-Moya, M., Guerrero, J., Ortiz, J. A., Ten, J., Lledo, B., Bernabeu, A., Bernabeu, R., & Castillo, J. C. (2025). Clinical outcomes in oocyte donation cycles: GnRH-antagonists versus progesterone-primed ovarian stimulation with micronized progesterone. Reproductive BioMedicine Online, 51(1), 104864. https://doi.org/10.1016/j.rbmo.2025.104864

Vancouver

Martinez-Moya M, Guerrero J, Ortiz JA, Ten J, Lledo B, Bernabeu A, et al. Clinical outcomes in oocyte donation cycles: GnRH-antagonists versus progesterone-primed ovarian stimulation with micronized progesterone. Reproductive BioMedicine Online. 2025;51(1):104864. doi:10.1016/j.rbmo.2025.104864

BibTeX
@article{MartinezMoya2025,
  author = {Martinez-Moya, Maria and Guerrero, Jaime and Ortiz, Jose Antonio and Ten, Jorge and Lledo, Belen and Bernabeu, Andrea and Bernabeu, Rafael and Castillo, Juan C},
  title = {Clinical outcomes in oocyte donation cycles: GnRH-antagonists versus progesterone-primed ovarian stimulation with micronized progesterone},
  journal = {Reproductive BioMedicine Online},
  year = {2025},
  volume = {51},
  number = {1},
  pages = {104864},
  doi = {10.1016/j.rbmo.2025.104864}
}
Kostenlos starten →